It has been reported in the literature that there is a regulatory relationship between IL17A, Del-1 and resolvinD1, so the level of resolvinD1 in the CSF of RRMS patients was also detected (29). This evidence concerns the gene IL17A and relapsing-remitting multiple sclerosis.